Literature DB >> 33150

Genetic analysis of Staphylococcus aureus RNA polymerase mutants.

T O Morrow, S A Harmon.   

Abstract

Spontaneous mutants of Staphylococcus aureus resistant to rifampin, rifamycin SV, streptovaricin, or streptolydigin were isolated and shown to be resistant due to chromosomal rather than plasmid mutations. Based on data concerning spontaneous mutation rates, genetic cotransduction rates, and in vitro sensitivity studies, four major antibiotic cross-resistance patterns were found. The genetic markers responsible for these cross-resistance patterns were shown to be separable by transduction. Nonpurified RNA polymerase activity in lysates of mutants showed the same sensitivity to these antibiotics as shown by the mutants on solid media. A model is proposed explaining possible structure-function relationships involved in the binding of these antibiotics to the RNA polymerase molecule and the mutations resulting in resistance to these antibiotics. This model includes generally overlapping but different-sized binding sites on the RNA polymerase protein coded for by similarly arranged mutable sites on the DNA.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 33150      PMCID: PMC218460          DOI: 10.1128/jb.137.1.374-383.1979

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  23 in total

1.  Reconstitution of bacterial DNA-dependent RNA-polymerase from isolated subunits as a tool for the elucidation of the role of the subunits in transcription.

Authors:  A Heil; W Zillig
Journal:  FEBS Lett       Date:  1970-12       Impact factor: 4.124

2.  Streptovaricin. I. Discovery and biologic activity.

Authors:  P SIMINOFF; R M SMITH; W T SOKOLSKI; G M SAVAGE
Journal:  Am Rev Tuberc       Date:  1957-04

3.  Permeability barrier to rifampin in mycobacteria.

Authors:  J Hui; N Gordon; R Kajioka
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

4.  RNA polymerase mutants of Escherichia coli. Streptolydigin resistance and its relation to rifampicin resistance.

Authors:  Y Iwakura; A Ishihama; T Yura
Journal:  Mol Gen Genet       Date:  1973-03-01

5.  Chromosomal location of the genetic elements controlling penicillinase production in a strain of Staphylococcus aureus.

Authors:  E H Asheshov
Journal:  Nature       Date:  1966-05-21       Impact factor: 49.962

6.  Inhibition of initiation of DNA-dependent RNA synthesis by an antibiotic B44p.

Authors:  S Mizuno; H Yamazaki; K Nitta; H Umezawa
Journal:  Biochem Biophys Res Commun       Date:  1968-02-26       Impact factor: 3.575

7.  Action of rifamycin on RNA-polymerase from sensitive and resistant bacteria.

Authors:  W Wehrli; F Knüsel; M Staehelin
Journal:  Biochem Biophys Res Commun       Date:  1968-07-26       Impact factor: 3.575

8.  Characterization of T7 specific RNA polymerase. 3. Inhibition by derivatives of rifamycin SV.

Authors:  M J Chamberlin; J Ring
Journal:  Biochem Biophys Res Commun       Date:  1972-11-15       Impact factor: 3.575

9.  Evidence for a new diffusible element of mating pheromones in yeast.

Authors:  J B Hicks; I Herskowitz
Journal:  Nature       Date:  1976-03-18       Impact factor: 49.962

Review 10.  Rifampicin, a general review.

Authors:  G Binda; E Domenichini; A Gottardi; B Orlandi; E Ortelli; B Pacini; G Fowst
Journal:  Arzneimittelforschung       Date:  1971-12
View more
  3 in total

1.  Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant Staphylococcus aureus.

Authors:  T A Wichelhaus; V Schäfer; V Brade; B Böddinghaus
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

Review 2.  Antimicrobial resistance of Staphylococcus aureus: genetic basis.

Authors:  B R Lyon; R Skurray
Journal:  Microbiol Rev       Date:  1987-03

3.  Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus.

Authors:  H Aubry-Damon; C J Soussy; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.